Conclusion of a non-exclusive rebate agreement pursuant to § 130a para. 8 SGB V for medicinal products with the active ingredient hydroxycarbamide (ATC code: L01XX05) within the period from 01.02.2024 to 31.01.2026 with the possibility of concluding a contract at any time during the term ("open-house model").

For the active ingredient hydroxycarbamide (ATC code: L01XX05), the AOK Niedersachsen. For the period until the entry into force of exclusive contracts following a formal award procedure in accordance with the regulations of Part 4 of the GWB, the health insurance fund will offer rebate agreements to all interested pharmaceutical companies, without a selection decision. The contracts are concluded within the framework of an "open-house model" and act as a bridge between the start of generic competition (patent expiration) and the award of exclusive contracts. The contracts offered are non-exclusive; Contracts with all market participants (pharmaceutical companies) are desired by AOK Niedersachsen. In the open-house model, uniform conditions apply to all participants. The content of the contract, conditions and access procedures are uniform – individual negotiations are generally not conducted. The contract periods are a maximum of twenty-four months, the earliest contract start date is 01.02.2024. All contracts end on 31.01.2026 at the latest, regardless of the date of conclusion of the respective contract. Accession or conclusion of a contract can take place within the twenty-four-month period on the first of each month. There is a right of termination six weeks to the end of each month. The AOK Niedersachsen. The health insurance fund reserves the right to replace the non-exclusive open-house discount agreements with exclusive discount contracts during the term of the contract. With the entry into force of tendered, exclusive discount agreements, the open-house contracts are terminated in accordance with the contractual provisions, i.e. the open-house contracts end automatically. According to the experience of AOK Niedersachsen, exclusive rebate agreements usually enter into force six to eight months after the publication of the corresponding tender notice in the Supplement to the Official Journal of the European Union. The future contractors in the open house model are requested to regularly inform themselves about these tender notices in the Supplement to the Official Journal of the European Union.

Interested pharmaceutical companies can request the contractual documents and the contractual terms and conditions at the contact address given under I.1).

Contracts for the active ingredient hydroxycarbamide (ATC code: L01XX05) will be concluded for the first time with effect from 01.02.2024. Interested parties who would like to become contractual partners on this date must submit the contract documents to be submitted by 04.01.2024 to the address given in the contract documents. It depends on the access at the AOK Niedersachsen. Later contracts can be concluded on the first of each month during the twenty-four-month maximum term. From an organisational point of view, a lead time of usually 35 calendar days is necessary on the part of the AOK in order to be able to guarantee the necessary work, e.g. the contract notification in the Lauer-Taxe®. The exact deadlines for receipt will be announced with the contract documents. This publication does not constitute the award of a public contract within the meaning of Directive (2014/24/EU) or public procurement law. In order to ensure the greatest possible degree of transparency for the intended conclusion of contracts, they will be published in the Supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used. The resulting conceptual specifications, e.g. the procedure designation "open procedure" is solely due to the use of this announcement form and the publication platform. This does not have any further significance, in particular a submission to regulations under public procurement law, insofar as they are not binding for legal reasons.